The unique ability of DIF-3 to inhibit the mTOR pathway and to induce non-apoptotic cell death is potentially of great interest in cancer therapy because cancer cells often display defects in apoptosis, and targeting other modes of cell death could contribute to eradicating tumor cells. This evidence concerns the gene MTOR and neoplasm.